Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation

Figure 8

SLC25A32 functional enrichment analysis in breast cancer. (a–c) GSEA enrichment analysis revealed significant enrichment of SLC25A32 in WP_FOCAL_ADHESIONPI3KAKTMTORSIGNALING_PATHWAY, REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION, and BCAT_BILD_ET_AL_DN pathway in breast cancer. (d) String plots reveal the combined logFC analysis of GO/KEGG. (e) Bubble plots presenting the GO/KEGG enriched pathways of SLC25A32 in breast cancer.

(a)

(b)

(c)

(d)

(e)